Drugdiscovery >> Pharmaceutical Companies >> News
4676
Views
Celgene, PharmAkea partnership - drugdiscovery.com
Celgene, PharmAkea partnership - drugdiscovery.com


Celgene has entered into a collaboration with a biotech upstart PharmAkea Therapeutics, signing a three-deal to collaborate on cancer and cystic fibrosis drug development.
Read More >>


Tags: Celgene, PharmAkea Therapeutics, partnership, collaboration, cancer, cystic fibrosis, CF, drug development - October 6, 2013
Related Articles
1656
Views
Life Tech -  RainTree partnership Life Tech - RainTree partnership
Life Technologies Corporation and RainTree Oncology Services have entered into a collaboration agreement designed to further the advancement of personalized care for cancer patients. Read More >>

Tags: Life Technologies Corporation, RainTree Oncology Services, cooperation, partnership, personalized care, cancer patients

2872
Views
Second agreement between FORMA and Celgene Second agreement between FORMA and Celgene
FORMA Therapeutics announced that its is going to ollaborate with Celgene Pharmaceuticals. The contract states that Celgene can use FORMA's platforms to develop new drugs. Read More >>

Tags: Forma Pharmaceuitcals, drug development, celgene, contribution, pharmaceutical companies, pharmaceutical contribution

3185
Views
Shire and Santaris  extend their partnership Shire and Santaris extend their partnership
The two companies decided to extend the agreement for discovering drug targets for rare genetic diseases that was signed in 2009, this way allowing Shire to nominate extra collaboration targets for Read More >>

Tags: Shire, Santaris, partnership, colaboration

1526
Views
Start-ups in the fielf of Drug Discovery are blossoming Start-ups in the fielf of Drug Discovery are blossoming
Lilly, Celgene, Sanofi, Roche are pioneers of a new way of grounding companies. Start-ups are now blossoming. The quesiton is how sustainable this technology will prove to be. Read More >>

Tags: start-up company, Lilly, Celgene, Sanofi, Roche

989
Views
Spero starts a new figth against resistant bacteria Spero starts a new figth against resistant bacteria
Spero has entered into a partnership with Roche based on antibiotics. The research aims to find a new treatment for resisitant bacterial infections. Read More >>

Tags: spero. antibiotics, partnership, Roche, drugs, drug development

3238
Views
UCB and Sanofi started a new partnership UCB and Sanofi started a new partnership
Belgium-based UCB and Sanofi announced that they entered into a new strategic partnership.The new contract aims to develop treatmens for immune-based diseases in the field of gastroenterology and arth Read More >>

Tags: Sanofi, UCB , arthritis, gastroenterology

5044
Views
Sunovion Pharma and Afraxis join forces in CNS drug discovery Sunovion Pharma and Afraxis join forces in CNS drug discovery
The companies have signed a collaboration agreement to boost Sunovion’s preclinical central nervous system (CNS) drug discovery process by using a unique enhanced spine platform developed by Afraxis Read More >>

Tags: Sunovion, Afraxis, partnership,colaboration, CNS drugs

4894
Views
AstraZeneca: New Partnership in Combat Kidney Disease AstraZeneca: New Partnership in Combat Kidney Disease
Evotec AG and AstraZeneca step into fellowship to fight kidney disease. The two giants are working on finding new possibilities and components, which might modify disease and help the quick recovery o Read More >>

Tags: contrect, Evotec AG, AstraZeneca, kidney

1326
Views
Particle Sciences signs joint development with Actavis Particle Sciences signs joint development with Actavis
Particle Sciences has signed a contract with Actavis. The company is going to be responsible for the design and formulation of cGMP supplies of the pharmacutical company. Read More >>

Tags: generic drugs, generic drug news, Actavis, Particle Scinences, pharmaceutical partnership

1948
Views
A partership between Novartis and Ensemble Therapeutics A partership between Novartis and Ensemble Therapeutics
The two companies have signed the agreement to join their forces in development of experimental therapeutic candidates for the treatment of autoimmune diseases. Read More >>

Tags: Novartis, Ensemble Therapeutics, pact, partnership, inflammation, IL-17, autoimmune diseases

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013